ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1033

Osteoporosis and Cardiovascular Disease: Mortality Trends Among Adults in the United States from 1999 to 2020

Muhammad Naveed1, Farman Ali2, Ahila Ali1, Bazil Azeem3, Faizan Ahmed4, Rabia Iqbal1, Muhammad Omer Rehan1, Nouman Shafique5, Syed Ishaq6, Aman Ullah7 and Sherif Eltawansy8, 1Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan, 2Corewell Health, Dearborn Hospital, Dearborn, MI, Dearborn, MI, 3Shaheed Mohtarma Benazir Bhutto Medical College Liyari, Karachi, Pakistan, 4Ameer-ud-Din Medical College, Lahore, Pakistan, 5AdventHealth Orlando, Orlando, FL, 6Sinai Hospital of Baltimore, Baltimore, MD, 7SSM Health St Louis University Hospital, St. Louis, MO, 8Jersey Shore University Medical Centre, Neptune, NJ

Meeting: ACR Convergence 2024

Keywords: Cardiovascular, gender, Mortality, osteoporosis, race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Healthcare Disparities in Rheumatology Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoporosis and cardiovascular disease (CVD) represent significant public health concerns. This study investigates the trends and demographic disparities in mortality due to osteoporosis and CVD. The studied population was adults aged 25 and older in the United States from 1999 to 2020.

Methods: We conducted a retrospective analysis using data from the CDC-WONDER database from 1999 to 2020. Age-adjusted mortality rates (AAMRs) per 100,000 persons were calculated, and trends were assessed using Average Annual Percentage Change (AAPC) and Annual Percentage Change (APC). Data were stratified by year, sex, race/ethnicity, and geographical regions.

Results: Between 1999 and 2020, osteoporosis and CVD accounted for 171,698 deaths among adults aged 25+ years in the U.S. Deaths primarily occurred in nursing homes/long-term care facilities (45.1%), followed by medical facilities (24.5%). The overall AAMR for osteoporosis and CVD-related deaths decreased from 5.0 in 1999 to 2.3 in 2020, with an AAPC of -4.68 (95% CI: -5.21 to -4.28, p < 0.000001). AAMRs initially increased slightly from 1999 to 2004 (APC: 0.95, p = 0.314737) but then significantly declined from 2004 to 2020 (APC: -6.37, p < 0.000001).
Adult women exhibited substantially higher AAMRs compared to men (women: 5.0; men: 1.1). The AAMR of both men and women decreased from 1999 till 2020, with the decrease more prominent in men [Men: AAPC: -4.75 (CI: -5.27 to -4.35) (p-value < 0.000001); Women: AAPC: -4.43, (CI: -4.88 to -4.09) (p-value < 0.000001)]. The highest AAMRs were among Whites (4.0), followed by Asians or Pacific Islanders (2.4), American Indians or Alaska Natives (2.1), Hispanics (1.8), and Blacks (1.1). All racial groups experienced decreases in AAMRs, most notably Whites (AAPC: -4.59, p < 0.000001). Geographically, AAMRs ranged from 1.1 in Louisiana to 13.8 in Vermont, with the Midwest having the highest regional AAMR (4.5). Nonmetropolitan areas had higher AAMRs than metropolitan areas (nonmetropolitan: 4.4; metropolitan: 3.4), with significant decreases observed in both (metropolitan AAPC: -4.63, p < 0.000001; nonmetropolitan AAPC: -4.18, p < 0.000001).

Conclusion: This analysis reveals a significant decline in mortality rates due to osteoporosis and CVD among adults in the U.S. over the past two decades. Results also indicate demographic and geographic disparities across the U.S. These disparities in AAMRs underscore the need for targeted interventions to address the specific healthcare needs of these populations.

Supporting image 1

Demographic Variations and Inequalities in Mortality from Osteoporosis and Cardiovascular Disease (CVD) among U.S Adults (aged 25+ years) from 1999 to 2020.


Disclosures: M. Naveed: None; F. Ali: None; A. Ali: None; B. Azeem: None; F. Ahmed: None; R. Iqbal: None; M. Rehan: None; N. Shafique: None; S. Ishaq: None; A. Ullah: None; S. Eltawansy: None.

To cite this abstract in AMA style:

Naveed M, Ali F, Ali A, Azeem B, Ahmed F, Iqbal R, Rehan M, Shafique N, Ishaq S, Ullah A, Eltawansy S. Osteoporosis and Cardiovascular Disease: Mortality Trends Among Adults in the United States from 1999 to 2020 [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/osteoporosis-and-cardiovascular-disease-mortality-trends-among-adults-in-the-united-states-from-1999-to-2020/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/osteoporosis-and-cardiovascular-disease-mortality-trends-among-adults-in-the-united-states-from-1999-to-2020/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology